Publications 2022

Bremer S, Henjum S, Sæther EM, Hovland R (2022)
Drug-related problems and satisfaction among patients receiving pharmacist-led consultations at the initiation of cardiovascular drugs
18 (11), 3939-3947
DOI 10.1016/j.sapharm.2022.06.005, PubMed 35750567

Publications 2020

Klaasen RA, Bergan S, Bremer S, Hole K, Nordahl CB, Andersen AM, Midtvedt K, Skauby MH, Vethe NT (2020)
Pharmacodynamic assessment of mycophenolic acid in resting and activated target cell population during the first year after renal transplantation
86 (6), 1100-1112
DOI 10.1111/bcp.14218, PubMed 31925806

Publications 2019

Hovland R, Bremer S, Frigaard C, Henjum S, Faksvåg PK, Saether EM, Kristiansen IS (2019)
Effect of a pharmacist-led intervention on adherence among patients with a first-time prescription for a cardiovascular medicine: a randomized controlled trial in Norwegian pharmacies
28 (4), 337-345
DOI 10.1111/ijpp.12598, PubMed 31886591

Publications 2018

Klaasen RA, Bergan S, Bremer S, Daleq L, Andersen AM, Midtvedt K, Skauby MH, Vethe NT (2018)
Longitudinal Study of Tacrolimus in Lymphocytes During the First Year After Kidney Transplantation
40 (5), 558-566
DOI 10.1097/FTD.0000000000000539, PubMed 30086087

Publications 2017

Bremer S, Vethe NT, Skauby M, Kasbo M, Johansson ED, Midtvedt K, Bergan S (2017)
NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantation
83 (11), 2494-2502
DOI 10.1111/bcp.13367, PubMed 28686294

Skauby RH, Bjerre A, Sæves I, Vethe NT, Bremer S, Svarstad A, Bergan S (2017)
Prednisolone and Prednisone Pharmacokinetics in Pediatric Renal Transplant Recipients-A Prospective Study
39 (5), 472-482
DOI 10.1097/FTD.0000000000000439, PubMed 28749817

Publications 2016

Bremer S, Bliksrud YT, Rootwelt H, Woldseth B, Tangeraas T, Saeves I, Watle SSV (2016)
Identification of a novel BCKDHA deletion causing maple syrup urine disease
Meta Gene, 10, 86-89
DOI 10.1016/j.mgene.2016.02.004

Vevelstad M, Øiestad EL, Bremer S, Bogen IL, Zackrisson AL, Arnestad M (2016)
Is toxicity of PMMA (paramethoxymethamphetamine) associated with cytochrome P450 pharmacogenetics?
261, 137-47
DOI 10.1016/j.forsciint.2016.02.027, PubMed 26930544

Publications 2015

Bergan S, Bremer S, Vethe NT (2015)
Drug target molecules to guide immunosuppression
49 (4-5), 411-8
DOI 10.1016/j.clinbiochem.2015.10.001, PubMed 26453533

Bremer S, Fløisand Y, Brinch L, Gedde-Dahl T, Bergan S (2015)
Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative Conditioning
37 (4), 493-500
DOI 10.1097/FTD.0000000000000180, PubMed 25565670

Kloster-Jensen K, Vethe NT, Bremer S, Abadpour S, Korsgren O, Foss A, Bergan S, Scholz H (2015)
Intracellular sirolimus concentration is reduced by tacrolimus in human pancreatic islets in vitro
28 (10), 1152-61
DOI 10.1111/tri.12617, PubMed 26046470

Robertsen I, Åsberg A, Ingerø AO, Vethe NT, Bremer S, Bergan S, Midtvedt K (2015)
Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed
99 (3), 528-32
DOI 10.1097/TP.0000000000000384, PubMed 25148382

Størset E, Åsberg A, Skauby M, Neely M, Bergan S, Bremer S, Midtvedt K (2015)
Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study
99 (10), 2158-66
DOI 10.1097/TP.0000000000000708, PubMed 25886918

Publications 2014

Lunde I, Bremer S, Midtvedt K, Mohebi B, Dahl M, Bergan S, Åsberg A, Christensen H (2014)
The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
70 (6), 685-93
DOI 10.1007/s00228-014-1656-3, PubMed 24658827

Saeves I, Line PD, Bremer S, Vethe NT, Tveit RG, Meltevik TJ, Bergan S (2014)
Tacrolimus Exposure and Mycophenolate Pharmacokinetics and Pharmacodynamics Early After Liver Transplantation
Ther. Drug Monit., 36 (1), 46-53

Størset E, Holford N, Hennig S, Bergmann TK, Bergan S, Bremer S, Åsberg A, Midtvedt K, Staatz CE (2014)
Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling
78 (3), 509-23
DOI 10.1111/bcp.12361, PubMed 25279405

Sæves I, Line PD, Bremer S, Vethe NT, Tveit RG, Meltevik TJ, Bergan S (2014)
Tacrolimus exposure and mycophenolate pharmacokinetics and pharmacodynamics early after liver transplantation
36 (1), 46-53
DOI 10.1097/FTD.0b013e31829dcb66, PubMed 24081206

Vethe NT, Ali AM, Reine PA, Andersen AM, Bremer S, Line PD, Rootwelt H, Bergan S (2014)
Simultaneous quantification of IMPDH activity and purine bases in lymphocytes using LC-MS/MS: assessment of biomarker responses to mycophenolic acid
36 (1), 108-18
DOI 10.1097/FTD.0b013e3182a13900, PubMed 24061448

Vethe NT, Ali AM, Reine PA, Andersen AM, Bremer S, Line PD, Rootwelt H, Bergan S (2014)
Simultaneous Quantification of IMPDH Activity and Purine Bases in Lymphocytes Using LC-MS/MS: Assessment of Biomarker Responses to Mycophenolic Acid
Ther. Drug Monit., 36 (1), 108-118

Publications 2013

Lærum H, Bremer S, Bergan S, Grünfeld T (2013)
A taste of individualized medicine: physicians' reactions to automated genetic interpretations
21 (e1), e143-6
DOI 10.1136/amiajnl-2012-001587, PubMed 24001515

Størset E, Holford N, Midtvedt K, Bremer S, Bergan S, Åsberg A (2013)
Importance of hematocrit for a tacrolimus target concentration strategy
70 (1), 65-77
DOI 10.1007/s00228-013-1584-7, PubMed 24071959

Åsberg A, Midtvedt K, van Guilder M, Størset E, Bremer S, Bergan S, Jelliffe R, Hartmann A, Neely MN (2013)
Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation
26 (12), 1198-207
DOI 10.1111/tri.12194, PubMed 24118301

Publications 2011

Bremer S, Ohlsson A, Brodtkorb E, Rootwelt H, Rootwelt T, Woldseth B, Mørkrid L (2011)
A novel mucopolysaccharidosis type I associated splice site mutation and IDUA splice variants
104 (3), 289-94
DOI 10.1016/j.ymgme.2011.07.012, PubMed 21831683

Publications 2009

Bremer S (2009)
Inosine monophosphate dehydrogenase: the molecular target of mycophenolate
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 820, 1 b. (flere pag.)
BIBSYS 093605684, ISBN 978-82-8072-345-1

Bremer S, Vethe NT, Rootwelt H, Jørgensen PF, Stenstrøm J, Holdaas H, Midtvedt K, Bergan S (2009)
Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study
7, 64
DOI 10.1186/1479-5876-7-64, PubMed 19635156

Publications 2008

Bremer S, Mandla R, Vethe NT, Rasmussen I, Rootwelt H, Line PD, Midtvedt K, Bergan S (2008)
Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression
85 (1), 55-61
DOI 10.1097/01.tp.0000296854.68123.03, PubMed 18192912

Bremer S, Vethe NT, Rootwelt H, Bergan S (2008)
Expression of IMPDH1 is regulated in response to mycophenolate concentration
9 (2), 173-80
DOI 10.1016/j.intimp.2008.10.017, PubMed 19010451

Falck P, Asberg A, Byberg KT, Bremer S, Bergan S, Reubsaet JL, Midtvedt K (2008)
Reduced elimination of cyclosporine A in elderly (>65 years) kidney transplant recipients
86 (10), 1379-83
DOI 10.1097/TP.0b013e31818aa4b6, PubMed 19034006

Falck P, Asberg A, Guldseth H, Bremer S, Akhlaghi F, Reubsaet JL, Pfeffer P, Hartmann A, Midtvedt K (2008)
Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients
85 (2), 179-84
DOI 10.1097/TP.0b013e31815feede, PubMed 18212621

Vethe NT, Bremer S, Bergan S (2008)
IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine
68 (4), 277-85
DOI 10.1080/00365510701724871, PubMed 18609073

Vethe NT, Bremer S, Rootwelt H, Bergan S (2008)
Pharmacodynamics of mycophenolic acid in CD4+ cells: a single-dose study of IMPDH and purine nucleotide responses in healthy individuals
30 (6), 647-55
DOI 10.1097/FTD.0b013e31818955c3, PubMed 18806697

Publications 2007

Bremer S, Rootwelt H, Bergan S (2007)
Real-time PCR determination of IMPDH1 and IMPDH2 expression in blood cells
53 (6), 1023-9
DOI 10.1373/clinchem.2006.081968, PubMed 17463174

Publications 2004

Bremer S (2004)
IMPDH type I og II ekspresjon i blodceller: utvikling, validering og etablering av relativ kvantitativ RT-PCR analyse : eksprejonsendringer hos nyretransplanterteunder mykofenolatbehandling
S. Bremer, Oslo, x, 86 s.
BIBSYS 042138302